The projected fair value for ImmuCell is US$8.22 based on 2 Stage Free Cash Flow to Equity With US$6.60 share price, ImmuCell appears to be trading close to its estimated fair value ImmuCell's peers ...
WESCO International's estimated fair value is US$197 based on 2 Stage Free Cash Flow to Equity. WESCO International's US$214 share price indicates it is trading at s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback